U.S. Physical Therapy hosted an earnings call to discuss its financial results for the third quarter and nine months ended September 30, 2026. The company reported record volume with 27 consecutive months of record visits and successfully transitioned its Metro New York facilities into the NYU Langone hospital partnership.
Term
Q3 2026
“With respect to visits, every month this year has been a record for that month. We are up to 27 consecutive months where that has occurred, nearly 2.5 years of record volume each and every month.”
U.S. Physical Therapy, Inc. reported its financial results for the period ended September 30, 2026. The filing was made under Item 2.02, which is the standard SEC disclosure for quarterly or annual results of operations and financial condition.
U.S. Physical Therapy, Inc. reported net revenue of $634.9 million for the nine months ended September 30, 2026, an increase from $578.3 million in the prior year. However, net income attributable to shareholders decreased to $26.0 million from $35.4 million, primarily due to higher operating costs and a loss on the change in fair value of contingent earn-out consideration.
U S Physical Therapy $171M Debt Financing with Bank of America, National Association
U.S. Physical Therapy, Inc. entered into a 45-month forward-starting interest rate swap agreement with Bank of America with an initial notional amount of $170.6 million. The swap fixes the variable interest rate on the company's existing term debt at 4.578% per annum effective June 30, 2027, through April 14, 2031. This transaction is designed to hedge interest rate risk associated with the company's Fourth Amended and Restated Credit Agreement.
U.S. Physical Therapy, Inc. has appointed Myra Davis to its Board of Directors, effective October 1, 2026. Ms. Davis currently serves as the Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital and brings over two decades of healthcare technology leadership experience to the board.